Nextech V Oncology S.C.S., SICAV-SIF

Overview

• HeadquartersN4¹

See how the biggest companies compare on our leaderboards

Corporate structure

Nextech V Oncology S.C.S., SICAV-SIF sits at the top of its group. 3 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (2 companies). Each entity in the chart links to its source.

Stakes it holds

Nextech V Oncology S.C.S., SICAV-SIF has told the SEC it owns more than 5% of 2 companies, latest first (Schedules 13D and 13G).

• Kinnate Biopharma Inc.SC 13G/A Feb 14, 2023 to Feb 14, 2024²
• PMV Pharmaceuticals, Inc.SC 13G/A Feb 14, 2022³